5-(5-chlorosulfonyl-3-hydroxythiophene-2-yl)-1-methyl-3-n-propyl-6,7-dihydro-1H-pyrazolo-[4,3-d]pyrimidin-7-one | 260781-05-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡唑并嘧啶类
• 英文名称: 5-(5-chlorosulfonyl-3-hydroxythiophene-2-yl)-1-methyl-3-n-propyl-6,7-dihydro-1H-pyrazolo-[4,3-d]pyrimidin-7-one
• 英文别名: 4-hydroxy-5-(1-methyl-7-oxo-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-5-yl)thiophene-2-sulfonyl chloride
• CAS: 260781-05-3
• 化学式: C₁₃H₁₃ClN₄O₄S₂
• 分子量: 388.856
• InChiKey: AHFXKVISHUOQJD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  24
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.31
• 拓扑面积：
  150
• 氢给体数：
  2
• 氢受体数：
  7

反应信息

• 作为反应物：
  描述：

  N-甲基哌嗪 、 5-(5-chlorosulfonyl-3-hydroxythiophene-2-yl)-1-methyl-3-n-propyl-6,7-dihydro-1H-pyrazolo-[4,3-d]pyrimidin-7-one 、 5-(5-chlorosulfonyl-3-ethoxythiophene-2-yl)-1-methyl-3-n-propyl-6,7-dihydro-1H-pyrazolo-[4,3-d]pyrimidin-7-one 以 甲醇 为溶剂， 反应 96.0h， 生成 5-[3-hydroxy-5-(4-methylpiperazin-1-ylsulfonyl)-2-thienyl]-1-methyl-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-7-one 、 5-[3-ethoxy-5-(4-methylpiperazin-1-ylsulfonyl)-2-thienyl]-1-methyl-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-7-one
  参考文献：
  名称：

  5-HETEROCYCLYL PYRAZOLO 4,3-D]PYRIMIDIN-7-ONES FOR THE TREATMENT OF MALE ERECTILE DYSFUNCTION

  摘要：

  公开号：

  EP1109814B1
• 作为产物：
  描述：

  氯磺酸 、 5-(3-ethoxy-2-thienyl)-1-methyl-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-7-one 反应 24.0h， 生成 5-(5-chlorosulfonyl-3-hydroxythiophene-2-yl)-1-methyl-3-n-propyl-6,7-dihydro-1H-pyrazolo-[4,3-d]pyrimidin-7-one 、 5-(5-chlorosulfonyl-3-ethoxythiophene-2-yl)-1-methyl-3-n-propyl-6,7-dihydro-1H-pyrazolo-[4,3-d]pyrimidin-7-one
  参考文献：
  名称：

  5-HETEROCYCLYL PYRAZOLO 4,3-D]PYRIMIDIN-7-ONES FOR THE TREATMENT OF MALE ERECTILE DYSFUNCTION

  摘要：

  公开号：

  EP1109814B1

文献信息

• 5-heterocyclyl pyrazolo[4,3-d]pyrimidin-7-ones for the treatment of male
  申请人：Janssen Pharmaceutica, N.V.

  公开号：US06077841A1

  公开（公告）日：2000-06-20

  The invention is directed to novel substituted 5-heterocyclyl pyrazolopyrimidinones and derivatives thereof, their synthesis and their use in treating sexual dysfunction in mammals, especially male erectile dysfunction. Pharmaceutical compositions containing the compounds and methods of using them to treat sexual dysfunction are also described.

  本发明涉及新型取代的5-杂环基嘧唑吡咯并咪唑酮及其衍生物，其合成以及在哺乳动物中治疗性功能障碍，特别是男性勃起功能障碍方面的应用。还描述了含有这些化合物的制药组合物以及使用它们治疗性功能障碍的方法。
• US6077841A
  申请人：——

  公开号：US6077841A

  公开（公告）日：2000-06-20
• [EN] 5-HETEROCYCLYL PYRAZOLO[4,3-D]PYRIMIDIN-7-ONES FOR THE TREATMENT OF MALE ERECTILE DYSFUNCTION<br/>[FR] PYRAZOLO[4,3-D]-PYRIMIDIN-7-ONES 5-HETEROCYCLYLE, SERVANT AU TRAITEMENT DES TROUBLES DE L'ERECTION CHEZ L'HOMME
  申请人：ORTHO MCNEIL PHARM INC

  公开号：WO2000014088A1

  公开（公告）日：2000-03-16

  The invention is directed to novel substituted 5-heterocyclyl pyrazolopyrimidinones and derivatives thereof, their synthesis and their use in treating sexual dysfunction in mammals, especially male erectile dysfunction. Pharmaceutical compositions containing the compounds and methods of using them to treat sexual dysfunction are also described.